Micromax is set to sell part of its 7.6% stake in the online travel booking service, which also counts Info Edge and Fosun Kinzon Capital as investors.

IAC, Alphabet, General Motors, Sumitomo, SK Holdings, American Express, Daimler and Liberty Mutual are in line for exits from the car sharing service.

The Adimab and GV-backed covid-19 antibody treatment developer has floated on Nasdaq at a $1.84bn valuation, about a year after it was founded.

Koito Manufacturing has committed $50m to a PIPE deal supporting the lidar sensor provider’s reverse merger with Nasdaq-listed GCAC.

The Ant Group, Aucfan, Emtek, Gree, Microsoft and Naver-backed digital marketplace owner’s shares on IDX jumped 25% on the first day of trading.

The multi-corporate-backed biologic pill developer has listed on the Nasdaq Global Market, pricing the shares below their range.

The offering would produce $500m, including up to $70.6m from the sale of new shares, and offer exits to Max Group and TVS.

The corporate-backed consumer credit platform operator will get a Nasdaq listing from the transaction, which will include $120m in Pipe financing co-led by Palantir Technologies.

UW's vaccine development company has listed on Nasdaq, with its shares rising on the first day of trading.

The GV-backed cardiovascular therapeutics company has priced an upsized offering on Nasdaq, with the shares closing just marginally higher on the first day.